Welcome to the DB Insurance Blog
The U.S. Centers for Disease Control and Prevention said on Friday it had identified 193 potential cases of severe lung illness tied to vaping in 22 states as of Aug. 22, including one adult in Illinois who died after being hospitalized.
(Reuters Health) - Family caregivers for dementia patients don't sleep as long or as well as other adults of the same age, a new study suggests.
The U.S. health regulator on Thursday categorized the recall of Edwards Lifesciences Corp's Sapien 3 Ultra delivery system as extremely serious, highlighting health risks associated with its use, but the products will remain on the market.
Four dominant e-cigarette manufacturers face a probe into the health impacts of their products, as the U.S. House Energy and Commerce Committee asked on Wednesday about the firms' research and marketing practices.
Drug distributor Cardinal Health Inc warned on Tuesday that its business could be hurt as it defends itself against several opioid-related lawsuits.
(Reuters Health) - Seniors may be more likely than younger adults to choke on vitamins and dietary supplements, or to have other problems swallowing them, especially when the pills are on the larger side, a new study suggests.
The Centers for Disease Control and Prevention is investigating a "cluster" of lung illnesses linked to e-cigarette use after such cases were reported in 14 states.
High levels of E.coli bacteria forced Tokyo officials to cancel the swimming segment of Saturday's Paratriathlon World Cup, raising concerns about next year's Summer Olympic and Paralympic Games.
AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on Friday, a big boost for the drugmaker struggling with rising competition for Humira, its blockbuster therapy for the same condition.
The U.S. Food and Drug Administration approved Roche Holding AG's treatment for adult and adolescent patients whose cancers have a genetic defect, the agency said on Thursday.
Novartis AG said on Wednesday it replaced the two top research and development executives at its Avexis unit after some data was manipulated from early testing of a gene therapy for infants that costs more than $2 million.
An intervention used to treat astronauts has relevance for people on the ground with medical conditions that cause repeated fainting, researchers say.
Scientists are a step closer to finding the first effective treatments for the deadly Ebola haemorrhagic fever after two potential drugs showed survival rate of as much as 90% in a clinical trial in Congo.
The World Health Organization said it has vaccinated over 1,300 people who potentially came into contact with the Ebola virus in the Congolese city of Goma, helping contain what many feared would be a rapid spread in an urban center.
Malaysia saw a rise in deaths caused by dengue to 113 by August 3, compared to 70 cases in the same period last year, the health ministry said on Saturday.
(Reuters Health) - Obesity simulation suits, worn by actors who play fake patients during training exercises, may help teach medical students about their own anti-fat prejudices, suggests a small study in Germany.
Chemicals in everything from food wrappers to clothing and furniture are associated with an increased risk of diabetes, but much of this added risk is reduced with good eating and exercise habits, a study suggests.
Gilead Sciences Inc hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contracting the infection, but the drugmaker faces opposition from an unusual source: patient advocates.
Serving the Treasure Valley and Southern Idaho, including Boise, Eagle, Meridian, Kuna, Nampa, Caldwell, Star, and Middleton for over 20 years. At Don Brown Insurance we make the process of finding the right plan for you and your family less complicated. Contact Don today for a free consultation.